The Price for Remdesivir

Gilead set the cost at $520 per dose in the United States

Gilead sets the pricing for remdesivir. The pharmaceutical company announced on Monday that it set pricing for its remdesivir treatment at $520 per dose in the United States. The company has been donating doses to the U.S. government since it received emergency use authorization in May.

Specifically, the company will sell remdesivir for $390 per vial to governments “of developed countries” around the world and the price for U.S. private insurance companies will stand…

--

--

--

A blog from Medium for Covid-19 news, advice, and commentary.

Recommended from Medium

40,000 Pharmacies Including Walgreens to Deliver Covid Vaccine

Fitbit Wants to Detect Early Covid-19 Symptoms

Day 230: 2020 Pandemic. A Surge And What You Need To Do

A Scientific Way to Assess Pandemic Threats

The Preppers Were Prepared for This

A Look at the Last Days of Lockdown in New York City

A Vaccine May Not Help the Elderly

COVID-19 testing

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
Coronavirus Blog Team

Coronavirus Blog Team

A real-time resource for news, advice, and commentary brought to you by Medium.

More from Medium

What other factors could affect EPS growth?

Demystifying Santa Cruz County’s Measure D

How to do Nightingale rose diagram visualization

Don’t forget to Breathe.